Copyright
©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 103035
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.103035
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.103035
Table 2 Cutoff National Early Warning Score 2 for mortality
Cutoff National Early Warning Score 2 for mortality | Sensitivity % (95%CI) | Specificity % (95%CI) | Positive predictive value % (95%CI) | Negative predictive value % (95%CI) | Accuracy % (95%CI) |
≥ 7 | 100 (63.06-100) | 50.92 (42.98-58.82) | 9.09 (7.88-10.47) | 100 (95.65-100) | 53.22 (45.45-60.87) |
≥ 8 | 100 (63.06-100) | 58.90 (50.93-66.53) | 10.67 (9.04-12.55) | 100 (96.23-100) | 60.82 (53.07-68.18) |
≥ 9 | 100 (63.06-100) | 69.94 (62.27-76.86) | 14 (11.44-17.10) | 100 (96.82-100) | 71.35 (63.94-77.99) |
≥ 10 | 100 (63.06-100) | 80.98 (74.10-86.7) | 20.51 (15.82-26.16) | 100 (97.24-100) | 81.87 (75.27-87.34) |
≥ 11 | 100 (63.06-100) | 84.66 (78.20-89.82) | 25.24 (18.24-31.46) | 100 (97.36-100) | 85.38 (79.18-90.31) |
≥ 12 | 100 (63.06-100) | 86.50 (80.28-91.34) | 26.67 (19.78-34.91) | 100 (97.42-100) | 87.13 (81.17-91.76) |
≥ 13 | 100 (63.06-100) | 89.57 (83.83-93.81) | 32 (23.08-42.46) | 100 (97.51-100) | 90.06 (84.56-94.10) |
≥ 14 | 100 (63.06-100) | 91.41 (86.01-95.22) | 36.36 (25.72-48.53) | 100 (97.55-100) | 91.81 (86.64-95.45) |
≥ 15 | 87.50 (47.35-99.68) | 96.93 (92.99-99) | 58.33 (36.23-77.53) | 99.37 (96.19-99.9) | 96.49 (92.52-98.70) |
≥ 16 | 75 (34.91-96.81) | 98.16 (94.72-99.62) | 66.67 (37.82-86.8) | 98.77 (96.01-99.63) | 97.08 (93.31-99.04) |
≥ 17 | 50 (15.7-84.3) | 98.77 (95.64-99.85) | 66.67 (29.97-90.34) | 97.58 (95.27-98.77) | 96.49 (92.52-98.7) |
≥ 18 | 25 (3.19-65.09) | 100 (97.76-100) | 100 (15.81-100) | 96.45 (94.79-97.59) | 96.49 (92.52-98.7) |
≥ 19 | 12.50 (0.32-52.65) | 100 (97.76-100) | 100 (2.50-100) | 95.88 (94.71-96.8) | 95.91 (91.75-98.34) |
- Citation: Krishnamoorthy S, Thiruvengadam G, Sekar H, Palaniyandi V, Ramadurai S, Narayanasamy S. Modified National Early Warning Score 2, a reliable early warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis. World J Nephrol 2025; 14(2): 103035
- URL: https://www.wjgnet.com/2220-6124/full/v14/i2/103035.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i2.103035